Tekamlo - 0078-0606-35 - (Aliskiren Hemifumarate and Amlodipine Besylate)

Alphabetical Index


Drug Information of Tekamlo

Product NDC: 0078-0606
Proprietary Name: Tekamlo
Non Proprietary Name: Aliskiren Hemifumarate and Amlodipine Besylate
Active Ingredient(s): 300; 10    mg/1; mg/1 & nbsp;   Aliskiren Hemifumarate and Amlodipine Besylate
Administration Route(s): ORAL
Dosage Form(s): TABLET, FILM COATED
Coding System: National Drug Codes(NDC)

Labeler Information of Tekamlo

Product NDC: 0078-0606
Labeler Name: Novartis Pharmaceuticals Corporation
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA022545
Marketing Category: NDA
Start Marketing Date: 20100101

Package Information of Tekamlo

Package NDC: 0078-0606-35
Package Description: 100 BLISTER PACK in 1 PACKAGE (0078-0606-35) > 1 TABLET, FILM COATED in 1 BLISTER PACK (0078-0606-61)

NDC Information of Tekamlo

NDC Code 0078-0606-35
Proprietary Name Tekamlo
Package Description 100 BLISTER PACK in 1 PACKAGE (0078-0606-35) > 1 TABLET, FILM COATED in 1 BLISTER PACK (0078-0606-61)
Product NDC 0078-0606
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Aliskiren Hemifumarate and Amlodipine Besylate
Dosage Form Name TABLET, FILM COATED
Route Name ORAL
Start Marketing Date 20100101
Marketing Category Name NDA
Labeler Name Novartis Pharmaceuticals Corporation
Substance Name ALISKIREN HEMIFUMARATE; AMLODIPINE BESYLATE
Strength Number 300; 10
Strength Unit mg/1; mg/1
Pharmaceutical Classes Renin Inhibitor [EPC],Renin Inhibitors [MoA],Calcium Channel Antagonists [MoA],Dihydropyridine Calcium Channel Blocker [EPC],Dihydropyridines [Chemical/Ingredient]

Complete Information of Tekamlo


General Information